3-Styryl-D-alanine
Need Assistance?
  • US & Canada:
    +
  • UK: +

3-Styryl-D-alanine

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Category
D-Amino Acids
Catalog number
BAT-007840
CAS number
264903-53-9
Molecular Formula
C11H13NO2
Molecular Weight
191.24
3-Styryl-D-alanine
IUPAC Name
(E,2R)-2-amino-5-phenylpent-4-enoic acid
Synonyms
D-Ala(styryl)-OH; D-Styrylalanine; (R)-2-Amino-5-phenylpent-4-enoic acid; (2R)-2-amino-5-phenyl-4-pentenoic acid; (R,E)-2-amino-5-phenylpent-4-enoic acid; (E)-D-Styrylalanine; beta-Styryl-D-alanine; 4-Pentenoic acid, 2-amino-5-phenyl-, (2R)-; H-D-Ala(Styr)-OH
Appearance
Almost white powder
Purity
≥ 99% (Assay by titration on dried basis)
Density
1.179±0.06 g/cm3 (Predicted)
Melting Point
238-242 °C
Boiling Point
399.4±42.0 °C (Predicted)
Storage
Store at 2-8 °C
InChI
InChI=1S/C11H13NO2/c12-10(11(13)14)8-4-7-9-5-2-1-3-6-9/h1-7,10H,8,12H2,(H,13,14)/b7-4+/t10-/m1/s1
InChI Key
MCGSKGBMVBECNS-LJJSCBMDSA-N
Canonical SMILES
C1=CC=C(C=C1)C=CCC(C(=O)O)N
1.Individual PKC-phosphorylation sites in organic cation transporter 1 determine substrate selectivity and transport regulation.
Ciarimboli G1, Koepsell H, Iordanova M, Gorboulev V, Dürner B, Lang D, Edemir B, Schröter R, Van Le T, Schlatter E. J Am Soc Nephrol. 2005 Jun;16(6):1562-70. Epub 2005 Apr 13.
To elucidate the molecular mechanisms underlying stimulation of rat organic cation transporter type 1 (rOCT1) by protein kinase C (PKC) activation, functional properties and regulation of rOCT1 stably expressed in HEK293 cells after site-directed mutagenesis of putative PKC phosphorylation-sites were compared with wild-type (WT) rOCT1 using microfluorometric measurements with the fluorescence organic cation 4-(4-(dimethylamino)styryl)-N-methylpyridinium (ASP(+)). Either substitutions of single (S286A, S292A, T296A, S328A, and T550A) or of all five PKC-sites (5x-PKC) with alanine suppressed PKC-induced stimulation of ASP(+) uptake, whereas regulation by p56(lck) tyrosine kinase was conserved in all mutants. Remarkably, the apparent affinities for TEA(+), TPA(+), and quinine were changed differently in each mutant (EC(50) in WT, S286A, S292A, T296A, S328A, T550A, and 5x-PKC in mumol: TEA(+): 105, 153, 56, 1135, 484, 498, 518; TPA(+): 0.1, 2.
2.An N-terminal threonine mutation produces an efflux-favorable, sodium-primed conformation of the human dopamine transporter.
Fraser R1, Chen Y1, Guptaroy B1, Luderman KD1, Stokes SL1, Beg A1, DeFelice LJ1, Gnegy ME2. Mol Pharmacol. 2014 Jul;86(1):76-85. doi: 10.1124/mol.114.091926. Epub 2014 Apr 21.
The dopamine transporter (DAT) reversibly transports dopamine (DA) through a series of conformational transitions. Alanine (T62A) or aspartate (T62D) mutagenesis of Thr62 revealed T62D-human (h)DAT partitions in a predominately efflux-preferring conformation. Compared with wild-type (WT), T62D-hDAT exhibits reduced [(3)H]DA uptake and enhanced baseline DA efflux, whereas T62A-hDAT and WT-hDAT function in an influx-preferring conformation. We now interrogate the basis of the mutants' altered function with respect to membrane conductance and Na(+) sensitivity. The hDAT constructs were expressed in Xenopus oocytes to investigate if heightened membrane potential would explain the efflux characteristics of T62D-hDAT. In the absence of substrate, all constructs displayed identical resting membrane potentials. Substrate-induced inward currents were present in oocytes expressing WT- and T62A-hDAT but not T62D-hDAT, suggesting equal bidirectional ion flow through T62D-hDAT.
Online Inquiry
Verification code
Inquiry Basket